Nir Erez has been chosen as one of the ten leading health care entrepreneurs that are changing the face of medicine in the world. Especially cancer care. Nir does this using a promising algorithm supported by a team of senior oncologists. In this way, Nir brings to the attention of patients information about the most studied and new treatments and drugs in the world, and later on, the company helps and works to make them accessible to patients in practice.
Nir Erez, founder and CEO of TRIAL-IN Pharma Ltd. has a vision – to break the barrier, change the statistics and increase the chances of curing cancer patients with stage four metastatic cancers and brain cancer. He has developed a model to locate groundbreaking cancer clinical trials and advanced treatments throughout the world, personally suited to the patient’s medical condition and background and make them accessible to those patients.
Chaque mois en Israël, près de 17 personnes décèdent, victimes du cancer de la peau. Avec un rayonnement solaire élevé tout au long de l'année, le mélanome menace les Israéliens, bien plus que les citoyens des pays du Nord. Du 17 au 21 juin, à l'occasion de la semaine de prévention contre ce fléau, il y a des consultations gratuites destinées à sensibiliser le public au danger du soleil sur la peau.
